Modulation of the growth of bifidobacteria by a combination of oligosaccharides from human milk

摘要

Liquid or dry prebiotic formulation for oral administration to a human, containing (a) 0.5-2 mg / ml of 2'-fucosyl-lactose and 1-4 mg / ml of 3'-sialyl-lactose and 0.5 -2 mg / ml of 6'-sialyl-lactose, when said formulation is liquid, or (b) at least 0.4% ep of 2'-fucosyl-lactose and at least 0.8% e.p. of 3'-sialyl-lactose and at least 0.4% e.p. of 6'-sialyl-lactose, when said formulation is a dry powder.